Barclays’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $224K | Sell |
9,115
-54,524
| -86% | -$1.29M | ﹤0.01% | 3622 |
|
|
2025
Q4 | $1.58M | Buy |
63,639
+5,225
| +9% | +$139K | ﹤0.01% | 3100 |
|
|
2025
Q3 | $1.66M | Sell |
58,414
-23,262
| -28% | -$630K | ﹤0.01% | 3012 |
|
|
2025
Q2 | $2.03M | Buy |
81,676
+23,767
| +41% | +$669K | ﹤0.01% | 2834 |
|
|
2025
Q1 | $1.8M | Sell |
57,909
-21,634
| -27% | -$721K | ﹤0.01% | 2712 |
|
|
2024
Q4 | $2.51M | Buy |
79,543
+2,627
| +3% | +$125K | ﹤0.01% | 2718 |
|
|
2024
Q3 | $4.46M | Buy |
76,916
+61,298
| +392% | +$3.01M | ﹤0.01% | 2186 |
|
|
2024
Q2 | $633K | Sell |
15,618
-24,120
| -61% | -$957K | ﹤0.01% | 2895 |
|
|
2024
Q1 | $1.67M | Sell |
39,738
-27,673
| -41% | -$1.08M | ﹤0.01% | 2727 |
|
|
2023
Q4 | $2.58M | Buy |
67,411
+44,723
| +197% | +$1.49M | ﹤0.01% | 2708 |
|
|
2023
Q3 | $700K | Buy |
22,688
+1,333
| +6% | +$46K | ﹤0.01% | 2580 |
|
|
2023
Q2 | $675K | Buy |
21,355
+1,600
| +8% | +$54.9K | ﹤0.01% | 2565 |
|
|
2023
Q1 | $720K | Buy |
19,755
+761
| +4% | +$26.6K | ﹤0.01% | 2981 |
|
|
2022
Q4 | $562K | Sell |
18,994
-1,162
| -6% | -$37.4K | ﹤0.01% | 3239 |
|
|
2022
Q3 | $786K | Buy |
20,156
+8,247
| +69% | +$378K | ﹤0.01% | 2391 |
|
|
2022
Q2 | $459K | Sell |
11,909
-18,500
| -61% | -$704K | ﹤0.01% | 2928 |
|
|
2022
Q1 | $1.47M | Sell |
30,409
-18,824
| -38% | -$971K | ﹤0.01% | 2110 |
|
|
2021
Q4 | $3.62M | Buy |
49,233
+19,146
| +64% | +$1.57M | ﹤0.01% | 1947 |
|
|
2021
Q3 | $2.74M | Buy |
30,087
+20,312
| +208% | +$1.73M | ﹤0.01% | 2089 |
|
|
2021
Q2 | $614K | Sell |
9,775
-7,185
| -42% | -$266K | ﹤0.01% | 2953 |
|
|
2021
Q1 | $460K | Buy |
16,960
+10,438
| +160% | +$251K | ﹤0.01% | 3231 |
|
|
2020
Q4 | $119K | Sell |
6,522
-2,507
| -28% | -$45.1K | ﹤0.01% | 4056 |
|
|
2020
Q3 | $163K | Buy |
9,029
+3,568
| +65% | +$61.6K | ﹤0.01% | 3972 |
|
|
2020
Q2 | $90K | Buy |
5,461
+2,755
| +102% | +$43.3K | ﹤0.01% | 4594 |
|
|
2020
Q1 | $36K | Sell |
2,706
-3,543
| -57% | -$57.8K | ﹤0.01% | 5404 |
|
|
2019
Q4 | $115K | Sell |
6,249
-7,541
| -55% | -$125K | ﹤0.01% | 5402 |
|
|
2019
Q3 | $243K | Buy |
13,790
+9,719
| +239% | +$166K | ﹤0.01% | 4830 |
|
|
2019
Q2 | $68K | Sell |
4,071
-4,255
| -51% | -$77.2K | ﹤0.01% | 5943 |
|
|
2019
Q1 | $153K | Buy |
8,326
+7,601
| +1,048% | +$146K | ﹤0.01% | 5035 |
|
|
2018
Q4 | $14K | Sell |
725
-16,395
| -96% | -$307K | ﹤0.01% | 6061 |
|
|
2018
Q3 | $378K | Buy |
17,120
+15,246
| +814% | +$321K | ﹤0.01% | 4496 |
|
|
2018
Q2 | $48K | Buy |
+1,874
| New | +$32.1K | ﹤0.01% | 5670 |
|
Other funds holding ASTH
VPM
3C
VCM
6CM
